Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):450-5. doi: 10.1016/j.ijrobp.2013.01.019. Epub 2013 Mar 6.

Abstract

Purpose: To determine the relative biological effectiveness (RBE) and the effective α/β ratio for local tumor control of a radioresistant rat prostate tumor (Dunning subline R3327-AT1) after 6 fractions of carbon ions and photons.

Methods and materials: A total of 82 animals with tumors in the distal thigh were treated with 6 fractions of either photons or carbon ions, by use of increasing dose levels and a 2-cm spread-out Bragg peak. Endpoints of the study were local control (no tumor recurrence within 300 days) and volumetric changes after irradiation. The resulting values for dose at 50% tumor control probability were used to determine RBE values. Including data for 1 and 2 fractions from a previous study, we estimated α/β ratios.

Results: For 6 fractions, the values for dose at 50% tumor control probability were 116.6 ± 3.0 Gy for photons and 43.7 ± 2.3 Gy for carbon ions and the resulting RBE was 2.67 ± 0.15. The α/β ratio was 84.7 ± 13.8 Gy for photons and 66.0 ± 21.0 Gy for carbon ions. Using these data together with the linear-quadratic model, we estimated the maximum RBE to be 2.88 ± 0.27.

Conclusions: The study confirmed the increased effectiveness of carbon ions relative to photons over the whole dose range for a highly radioresistant tumor. The maximum RBE below 3 is in line with other published in vivo data. The RBE values may be used to benchmark RBE models. Hypoxia seems to have a major impact on the radiation response, although this still has to be confirmed by dedicated experiments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Hypoxia
  • Dose Fractionation, Radiation
  • Dose-Response Relationship, Radiation
  • Heavy Ion Radiotherapy / methods*
  • Linear Models
  • Male
  • Photons / therapeutic use
  • Probability
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Tolerance
  • Rats
  • Relative Biological Effectiveness